QM/MM |
Hybrid Quantum Mechanics / Molecular Mechanics |
A subset of system simulated quantum mechanically (embedded in a larger MM environment) in order to allow bond breaking/formation, or to include molecules that cannot be adequately described by classical force fields
|
H+ transport |
[21, 23, 24, 27] |
ATP hydrolysis |
[31] |
MS-RMD |
Multiscale Reactive Molecular Dynamics |
Using purposely derived reactive force field to treat bond breaking/formation |
H+ transport |
[21, 24–27] |
CpHMD |
Constant pH Molecular Dynamics |
MD simulation allowing H+ exchange at specified sites (e.g., titratable protein side chain) |
Determine pKa of residue and pH-induced conformational transition |
[35] |
MDFF |
Molecular Dynamics Flexible Fitting |
Structural refinement method that dynamically fits an atomic structure into experimentally determined electron densities |
Refine low resolution molecular structure |
[20] |
FEP/TI |
Free Energy Perturbation / Thermodynamic Integration |
Calculate the energy difference between two related states by alchemically morphing one into the other |
Calculate binding energy |
[10, 14, 17–19, 45, 64, 68] |
determine residue pKa
|
[20] |
SMD |
Steered Molecular Dynamics |
Applying a force or a moving restraint to bias the movement of a (group of) atom(s), either in real space or in collective variable space |
Probe conformational transitions |
[11, 20, 42–45] |
Drug unbinding |
[62, 64] |
US |
Umbrella Sampling |
Restraining the system at multiple points along a specified reaction coordinate to calculate the potential of mean force |
Free energy calculations along specified reaction coordinate |
[24–26, 30, 45, 54] |
MetaD |
Metadynamics |
Calculate potential of mean force along a collective variable by inversely summing Gaussian potentials added during simulation to overcome energy barriers |
aMD |
Accelerated Molecular Dynamics |
Enhanced sampling method where a biasing potential is applied to the dihedral and/or total potential of the system |
Substrate binding |
[40] |
Conformational change |
[40, 41] |
MSM |
Markov State Model |
Describe the kinetic of the process using the transition rates between different substates, typically calculated from very long or many discrete MD simulations |
Ion release pathway |
[16] |
Conformation change |
[41, 49] |
|
String Method |
Path search/optimization method to obtain a pathway connecting two states with a least barrier |
Conformational change |
[42, 45] |
Binding pathway |
[64] |
CG |
Coarse Grained Simulation |
Represent simulation systems with coarser particles, each representing a group of atoms |
Lipid binding |
[50, 53, 54] |
|
Molecular Docking |
Predict ligand binding pose and energy to a target protein |
Predict substrate binding |
[40] |
Predict lipid/detergent binding |
[48] |
Predict drug binding |
[62, 67, 68] |
|
Ensemble Docking |
An ensemble of protein structures (often derived from MD simulations) are used for ligand docking, to account for the dynamics of the docking receptor |
Predict drug binding |
[63, 66] |